Ha habido 50 transacciones internas recientes registradas para Evoke Pharma, Inc. (EVOK), incluyendo 42 compras y 2 ventas. El total de compras internas fue valorado en $1.95M y el total de ventas internas en $30.25K.
Internos destacados con actividad reciente incluyen Nantahala Capital Management, Llc, Garner Cam L, Widder Kenneth J. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — EVOK
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2029-02-13 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Desconocido |
117,019 |
$8.16 |
$954.88K |
- |
| 2025-05-21 |
Garner Cam L |
Director |
Concesión de RSU |
1,291 |
$3.45 |
$4.46K |
11,520 |
| 2025-05-21 |
Widder Kenneth J |
Director |
Concesión de RSU |
1,187 |
$3.45 |
$4.1K |
8,207 |
| 2025-05-21 |
Reed Vickie S |
Director |
Concesión de RSU |
1,250 |
$3.45 |
$4.32K |
8,333 |
| 2025-05-21 |
Hill Malcolm R |
Director |
Concesión de RSU |
1,218 |
$3.45 |
$4.21K |
8,269 |
| 2025-05-21 |
Brady Todd C |
Director |
Concesión de RSU |
1,187 |
$3.45 |
$4.1K |
8,238 |
| 2025-05-21 |
Smeal Benjamin C. |
Director |
Concesión de RSU |
1,125 |
$3.45 |
$3.88K |
6,958 |
| 2025-05-21 |
Pyszczymuka Greg |
Director |
Concesión de RSU |
1,155 |
$3.45 |
$3.99K |
6,988 |
| 2025-03-21 |
D'onofrio Matthew J |
Chief Executive Officer |
Concesión de RSU |
1,000 |
$2.80 |
$2.8K |
9,820 |
| 2025-03-20 |
Kowieski Mark |
Chief Financial Officer |
Concesión de RSU |
4,500 |
$3.21 |
$14.46K |
4,916 |
| 2025-02-28 |
D'onofrio Matthew J |
Chief Executive Officer |
Concesión de RSU |
6,849 |
$3.65 |
$25K |
8,820 |
| 2025-02-20 |
Pyszczymuka Greg |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-02-20 |
Pyszczymuka Greg |
Director |
Concesión de RSU |
5,833 |
$5.26 |
$30.68K |
5,833 |
| 2025-01-28 |
Garner Cam L |
Director |
Concesión de RSU |
8,750 |
$4.45 |
$38.94K |
8,750 |
| 2025-01-28 |
Widder Kenneth J |
Director |
Concesión de RSU |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
Reed Vickie S |
Director |
Concesión de RSU |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
D'onofrio Matthew J |
Chief Executive Officer |
Concesión de RSU |
70,000 |
$4.45 |
$311.5K |
70,000 |
| 2025-01-28 |
Hill Malcolm R |
Director |
Concesión de RSU |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
Brady Todd C |
Director |
Concesión de RSU |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
Carlson Marilyn R. |
Chief Medical Officer |
Concesión de RSU |
11,000 |
$4.45 |
$48.95K |
11,000 |
| 2025-01-28 |
Kowieski Mark |
Chief Financial Officer |
Concesión de RSU |
13,000 |
$4.45 |
$57.85K |
13,000 |
| 2025-01-28 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Venta Informativa |
41 |
$4.39 |
$179.87 |
148,153 |
| 2024-11-06 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Desconocido |
- |
- |
- |
148,194 |
| 2024-10-18 |
Smeal Benjamin C. |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-10-18 |
Smeal Benjamin C. |
Director |
Concesión de RSU |
5,833 |
$5.51 |
$32.14K |
5,833 |
| 2024-09-27 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Desconocido |
250,627 |
$0.01 |
$2.51K |
- |
| 2024-08-07 |
D'onofrio Matthew J |
Chief Executive Officer |
Concesión de RSU |
64,840 |
$5.27 |
$341.71K |
64,840 |
| 2024-08-07 |
Carlson Marilyn R. |
Chief Medical Officer |
Concesión de RSU |
17,291 |
$5.27 |
$91.12K |
17,291 |
| 2024-08-07 |
Kowieski Mark |
Chief Financial Officer |
Concesión de RSU |
17,291 |
$5.27 |
$91.12K |
17,291 |
| 2024-05-22 |
Garner Cam L |
Director |
Concesión de RSU |
17,750 |
$0.45 |
$8.01K |
17,750 |
| 2024-05-22 |
Widder Kenneth J |
Director |
Concesión de RSU |
14,250 |
$0.45 |
$6.43K |
14,250 |
| 2024-05-22 |
Reed Vickie S |
Director |
Concesión de RSU |
15,000 |
$0.45 |
$6.77K |
15,000 |
| 2024-05-22 |
Hill Malcolm R |
Director |
Concesión de RSU |
14,625 |
$0.45 |
$6.6K |
14,625 |
| 2024-05-22 |
Brady Todd C |
Director |
Concesión de RSU |
14,625 |
$0.45 |
$6.6K |
14,625 |
| 2024-05-22 |
Kowieski Mark |
Chief Financial Officer |
Disposición |
7,500 |
$4.01 |
$30.08K |
- |
| 2024-02-13 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Desconocido |
245,080 |
$8.16 |
$2M |
- |
| 2023-05-10 |
Garner Cam L |
Director |
Concesión de RSU |
17,750 |
$2.12 |
$37.63K |
17,750 |
| 2023-05-10 |
Widder Kenneth J |
Director |
Concesión de RSU |
14,250 |
$2.12 |
$30.21K |
14,250 |
| 2023-05-10 |
Reed Vickie S |
Director |
Concesión de RSU |
15,000 |
$2.12 |
$31.8K |
15,000 |
| 2023-05-10 |
Hill Malcolm R |
Director |
Concesión de RSU |
14,625 |
$2.12 |
$31.01K |
14,625 |
| 2023-05-10 |
Brady Todd C |
Director |
Concesión de RSU |
14,625 |
$2.12 |
$31.01K |
14,625 |
| 2023-02-08 |
Gonyer David A |
CEO |
Concesión de RSU |
30,000 |
$4.01 |
$120.3K |
30,000 |
| 2023-02-08 |
D'onofrio Matthew J |
President & Chief Op. Officer |
Concesión de RSU |
25,000 |
$4.01 |
$100.25K |
25,000 |
| 2023-02-08 |
Carlson Marilyn R. |
Chief Medical Officer |
Concesión de RSU |
15,000 |
$4.01 |
$60.15K |
15,000 |
| 2022-04-27 |
Garner Cam L |
Director |
Concesión de RSU |
67,500 |
$0.66 |
$44.55K |
67,500 |
| 2022-04-27 |
Widder Kenneth J |
Director |
Concesión de RSU |
56,000 |
$0.66 |
$36.96K |
56,000 |
| 2022-04-27 |
Reed Vickie S |
Director |
Concesión de RSU |
58,000 |
- |
- |
58,000 |
| 2022-04-27 |
Hill Malcolm R |
Director |
Concesión de RSU |
57,750 |
$0.66 |
$38.12K |
57,750 |
| 2022-04-27 |
Brady Todd C |
Director |
Concesión de RSU |
57,750 |
$0.66 |
$38.12K |
57,750 |
| 2022-02-02 |
Gonyer David A |
President and CEO |
Concesión de RSU |
175,000 |
$0.55 |
$96.25K |
175,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
